XSHG600319
Market cap259mUSD
Dec 25, Last price
4.79CNY
1D
0.20%
1Q
27.68%
Name
Weifang Yaxing Chemical Co Ltd
Chart & Performance
Profile
Weifang Yaxing Chemical Co., Ltd. engages in the research and development, production, operation, import, and sale of chemical materials in China and internationally. It offers chlorinated polyethylene CPE, azodicarbonamide foaming agent, industrial hydrazine hydrate, sodium hydroxide, liquid chlorine, and hydrochloric acid. The company was founded in 1994 and is headquartered in Weifang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 824,850 -2.58% | 846,653 339.36% | 192,702 290.93% | |||||||
Cost of revenue | 841,012 | 748,393 | 204,064 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (16,162) | 98,261 | (11,363) | |||||||
NOPBT Margin | 11.61% | |||||||||
Operating Taxes | 406 | 10,265 | 23 | |||||||
Tax Rate | 10.45% | |||||||||
NOPAT | (16,568) | 87,995 | (11,386) | |||||||
Net income | 6,364 -94.15% | 108,844 -43.61% | 193,026 | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 298,200 | |||||||||
BB yield | -15.41% | |||||||||
Debt | ||||||||||
Debt current | 748,457 | 511,880 | 704,595 | |||||||
Long-term debt | 490,251 | 58,562 | 26,802 | |||||||
Deferred revenue | 54,107 | 55,289 | 56,471 | |||||||
Other long-term liabilities | 13,919 | 169,051 | 24,200 | |||||||
Net debt | 1,198,129 | 493,936 | 644,306 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (167,752) | 123,025 | ||||||||
CAPEX | (248,529) | |||||||||
Cash from investing activities | (247,694) | 31,988 | ||||||||
Cash from financing activities | 385,370 | 187,871 | ||||||||
FCF | (48,339) | (337,364) | (254,685) | |||||||
Balance | ||||||||||
Cash | 40,506 | 76,507 | 86,980 | |||||||
Long term investments | 73 | 1 | 110 | |||||||
Excess cash | 34,174 | 77,455 | ||||||||
Stockholders' equity | (431,067) | 607,043 | 534,876 | |||||||
Invested Capital | 1,967,592 | 1,341,059 | 961,452 | |||||||
ROIC | 7.64% | |||||||||
ROCE | 7.15% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 318,223 | 351,110 | 315,594 | |||||||
Price | 5.78 4.90% | 5.51 -0.72% | 5.55 6.94% | |||||||
Market cap | 1,839,328 -4.93% | 1,934,615 10.45% | 1,751,547 6.94% | |||||||
EV | 3,040,869 | 2,428,551 | 2,395,853 | |||||||
EBITDA | 48,027 | 150,646 | 10,303 | |||||||
EV/EBITDA | 63.32 | 16.12 | 232.54 | |||||||
Interest | 51,439 | 46,793 | 69,938 | |||||||
Interest/NOPBT | 47.62% |